
OI
USDO-I Glass Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$11.660
Máximo
$11.960
Mínimo
$11.520
Volumen
4.81M
Fundamentos de la Empresa
Capitalización de Mercado
1.8B
Industria
Packaging & Containers
País
United States
Estadísticas de Negociación
Volumen Promedio
1.42M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Informe de Análisis de IA
Última actualización: 2 nov 2025O-I Glass (OI): Navigating a Bear Market with Cautious Optimism
Price Action: A Steady Decline Under Pressure
OI stock has fallen 24% from its August peak ($13.42) to October’s close ($11.29). Technical indicators suggest:
- Support at $11.20: The stock tested this level in late October and bounced slightly.
- Weak momentum: MACD’s bullish crossover (0.0214 > 0.0116) and rising OBV (15.4x average) hint at short-term buying pressure, but ADX (15.0) signals a weak trend.
- Recent volatility: Daily moves of 2-3% common, yet the stock remains trapped below its 52-week high of $16.04.
News Sentiment: Mixed Signals Ahead of Earnings
- Truist’s lowered price target ($17 → $15.89 avg): Conflicting vibes--analysts still see 40.7% upside potential, but reduced targets may reflect caution.
- Earnings call on Nov 5: A key catalyst. Historically, OI’s glass packaging business struggles with negative revenue growth (-1.3%) and a sky-high debt-to-equity ratio (375x).
Predictive Outlook: AI vs. Reality
AI forecasts small gains (+1% to +2.2% over 3 days), but these lack confidence metrics. Long-term fundamentals remain shaky:
- P/E of 7.6x: Cheap vs. peers (11.4x), yet ROE (-15.7%) screams profitability issues.
- High debt: A red flag for stability, especially in a cyclical sector like packaging.
Strategic Recommendations: Play It Cautious
Entry: Consider buying near $11.19-11.27 if volume surges. Stop-loss: Set at $10.16 to limit downside from a breakdown. Take-profit: Target $11.52 (3% gain) for quick flips--aligns
Noticias Relacionadas
O-I Glass Reports Third Quarter 2025 Results
PERRYSBURG, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Stable Top-line With Significantly Higher Margins and EarningsContinued Strong Fit To Win Execution Drives Upgraded 2025 Earnings
Predicción de IABeta
Recomendación de IA
Actualizado el: 5 nov 2025, 05:10
62.8% Confianza
Riesgo y Negociación
Punto de Entrada
$11.65
Toma de Ganancias
$12.01
Stop Loss
$10.59
Factores Clave
Acciones Relacionadas
AKRO
Akero Therapeutics Inc.
HTIA
Healthcare Trust Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
MRSN
Mersana Therapeutics Inc.
BIVI
BioVie Inc.
CTCX
Carmell Corporation
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.